View in EDS

A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG.

Saved in:
Bibliographic Details
Title: A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG.
Authors: Banerjee, S.1, Rustin, G.2, Paul, J.3, Williams, C.4, Pledge, S.5, Gabra, H.6, Skailes, G.7, Lamont, A.8, Hindley, A.7, Goss, G.9, Gilby, E.10, Hogg, M.7, Harper, P.11, Kipps, E.1, Lewsley, L-A3, Hall, M.2, Vasey, P.12, Kaye, S. B.1
Source: Annals of Oncology. Mar2013, Vol. 24 Issue 3, p679-687. 9p. 1 Diagram, 4 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mds494